Pluristem COO to Present at Phacilitate Cell & Gene Therapy World Conference in Washington DC on January 25-26, 2016

Pluristem Therapeutics Inc. PSTI today announced that the Company's President and COO Yaky Yanay will deliver two presentations at the 12th Annual Phacilitate Cell & Gene Therapy World Conference which takes place January 25-27, 2016 in Washington D.C. On Monday, January 25 at 3:00pm Mr. Yanay will present "Pursuing clinical development as an in house manufacturer under the new regulations in Japan" during the session titled "Sharing Experiences to Date of Western Industry Trailblazers Seeking to Access the Japanese Regenerative Medicine Marketplace." On Tuesday, January 26 at 3:15pm Mr. Yanay's presentation titled "Industry perspective on the EMA Adaptive Pathway" will be part of Focus Session 2 "Accelerated clinical development pathways across the globe – what evidence of benefits to date for cell & gene therapy?" This year's conference, titled "From Promise to Products," features a one-day Japan Executive Summit which will focus on the novel regulatory pathways that have opened up in the Japanese regenerative medicine arena. Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has cleared Pluristem's PLX-PAD cells for use in clinical trials in See full press release